Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DIOVAN
- 24 Hour Ambulatory Cardiac Oxygen Consumption
- Effect of LCZ696 on Urinary Microalbumin and Pulse Wave Velocity in Perimenopausal Patients With Hypertension
- The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
- Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802
- Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
- : Vascular Function in Health and Disease
- EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
- Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
- Chronopharmacology of Valsartan in Normotensive Subjects
- Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients
- Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg
- Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
- Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg
- Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
- A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
- Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients
- Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
- A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
- Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
- Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
- ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
- Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
- A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers
- Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
- To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
- Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
- Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus
- A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
- Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
- Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
- Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
- Regression of Fatty Heart by Valsartan Therapy
- Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)
- Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
- Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
- The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
- Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris
- The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
- A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.
- A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients
- Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.
- Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
- Prevention of CHOP-induced Chronic Cardiotoxicity
- Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
- Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
- Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose
Clinical trials list
click for details